PANDEMIC - CBDC -FREEDOM - TRUTH

EUROPEAN PARLAMENT INTERNATIONAL COVID SUMMIT 3 “You Cannot Comply Your Way Out of Tyranny”: The Explosive Speech That Shook the European Parliament What happened inside the European Parliament during this international summit was not routine politics. It was not diplomatic language. And it was certainly not business as usual. What you are about to watch — and what this post introduces — is a raw, uncompromising denunciation of how the COVID era was handled, framed not as a public health response, but as a global experiment in control, compliance, and psychological warfare . A Historic Summit — And a Breaking Point Held inside one of the most important institutional venues in Europe, this conference brought together members of the global scientific, medical, and legal community. From the outset, it was described as unique and historic — not only for the quality of its speakers, but for the gravity of the issues addressed. Very quickly, however, the tone shifted from forma...

  A 65-year-old woman: diagnosed with autoimmune hepatitis after receiving the 1st dose of #CovidVaccine (Moderna). https://www.sciencedirect.com/science/article/pii/S0896841121001499?via%3Dihub "Molecular mimicry is a potential mechanism for COVID-19 vaccine-induced autoimmunity." Autoimmune hepatitis after COVID-19 vaccine – more than a coincidence Highlights • A 65-year-old woman was diagnosed with autoimmune hepatitis after receiving the first dose of SARS-CoV-2 vaccine. • Liver histology showed inflammatory portal infiltrate with interface hepatitis, centrilobular inflammation and necrosis. • The patient showed improvement in liver function tests and normalization of IgG levels under treatment with corticosteroids. • Molecular mimicry is a potential mechanism for COVID-19 vaccine-induced autoimmunity. We report a case of a 65-year-old woman who experienced acute severe  autoimmune hepatitis  two weeks after receiving the first dose of Moderna-COVID-19 vaccine. Serum...

  Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 #vaccination : "In summary, we cannot exclude the possibility that the #Pfizer and #Moderna vaccines have the potential to trigger de novo ITP (including clinically undiagnosed cases) ..." Thrombocytopenia following Pfizer and Moderna  SARS‐CoV ‐2 vaccination Eun‐Ju Lee ,  1  Douglas B. Cines ,  2  Terry Gernsheimer ,  3  Craig Kessler ,  4  Marc Michel ,  5  Michael D. Tarantino ,  6  John W. Semple ,  7  Donald M. Arnold ,  8  Bertrand Godeau ,  5  Michele P. Lambert ,  9 ,  10  and  James B. Bussel  11 Cases of apparent secondary immune thrombocytopenia (ITP) after SARS‐CoV‐2 vaccination with both the Pfizer and Moderna versions have been reported and reached public attention. Public alarm was heightened following the death of the first identified patient from an intracranial hemorrhage, which was rep...

Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older   Results Of 2 392 924 KPSC members who received at least 1 dose of COVID-19 mRNA vaccines, 50.2% received mRNA-1273 and 50.0% BNT162b2. In this cohort, 54.0% were women, 31.2% White, 6.7% Black, 37.8% Hispanic, and 14.3% were Asian individuals. Median age was 49 years (IQR, 34-64 years), 35.7% were younger than 40 years, and 93.5% completed 2 doses of vaccines. In the unexposed group of 1 577 741 individuals, median (IQR) age was 39 (28-53) years, 53.7% were younger than 40 years, 49.1% women, 29.7% White, 8.8% Black, 39.2% Hispanic, and 6.6% were Asian individuals. There were 15 cases of confirmed myocarditis in the vaccinated group (2 after the first dose and 13 after the second), for an observed incidence of 0.8 cases per 1 million first doses and 5.8 cases per 1 million second doses over a 10-day observation window ( Table 1 ). All were men, with a median (IQR) age of 25 (20-32) years. Among...

  Immune-mediated hepatitis secondary to #COVIDVaccination (Moderna): https://www.journal-of-hepatology.eu/article/S0168-8278(21)02093-6/fulltext "Long-term follow up of identified individuals will be essential in determining the prognosis of this immune-mediated liver injury." Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed. Gloria SZ. Tun Dermot Gleeson Asha Dube Amer Al-Joudeh Published: October 04, 2021 DOI: https://doi.org/10.1016/j.jhep.2021.09.031 Case description 47-year-old Caucasian man, previously completely well, received 1st Moderna vaccine dose on the 26 April 2021. He noted malaise and jaundice three days after. Investigations on the 30 th  April showed serum bilirubin 190 μmol/L (normal 0-20), ALT 1048 U/L (normal 10-49), ALP 229 U/L (normal 30-130), albumin 41 g/L (normal 35-50). Blood count, renal function and INR were normal. Liver function tests (LFTs) last checked 4 years previously were normal. He denied paracet...

Acute transverse myelitis following COVID-19 vaccination: Acute Transverse Myelitis Following COVID-19 Vaccination Jhih-Jian Gao   1 ,  Hung-Pin Tseng   1 ,  Chun-Liang Lin   1 ,  Jr-Shiang Shiu   2 ,  Ming-Hsun Lee   3 ,  Ching-Hsiung Liu   1 Affiliations  expand PMID:  34579245   PMCID:  PMC8470728   DOI:  10.3390/vaccines9091008 Free PMC article Abstract An increasing number of people are undergoing vaccination for COVID-19 because of the ongoing pandemic. The newly developed, genetically engineered mRNA vaccines are critical for controlling the epidemic disease. However, major adverse effects, including neuroimmunological disorders, are being attributed to this vaccine. For instance, several cases of acute transverse myelitis (ATM) after COVID-19 vaccination have been reported in clinical trials. Here, we report an exceedingly rare case of longitudinally extensive transverse myelitis (LETM), a rare ...